Welcome to our dedicated page for CNO Financial Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CNO Financial Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CNO Financial Group's regulatory disclosures and financial reporting.
CNO Financial Group Chief Financial Officer Paul H. McDonough reported equity compensation changes. On February 10, 2026, he acquired 42,309 shares of common stock upon vesting of performance share units tied to 2023–2025 financial and shareholder return metrics, then surrendered 15,374 shares to CNO to satisfy tax withholding at $43.05 per share. He also received a grant of 25,600 restricted stock units at no cost, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, subject to continued employment. Following these transactions, he beneficially owned 248,002.077 shares of common stock directly.
CNO Financial Group’s Chief Information Officer, Michael E. Mead, reported equity compensation activity. On February 10, 2026, he acquired 7,088 shares of common stock at $43.05 per share upon vesting of performance share units and then surrendered 2,951 shares at the same price to cover tax withholding. After these transactions, he directly held 19,866 common shares. He also received a grant of 4,600 restricted stock units, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, bringing his restricted stock unit balance to 24,466 units.
CNO Financial Group’s Chief Marketing Officer Rocco F. Tarasi III reported equity compensation activity on common stock. On February 10, 2026, he acquired 13,835 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023–2025 operating and shareholder-return metrics.
On the same date, 4,219 shares were surrendered back to the company at $43.05 per share to cover required tax withholding on those vested units. He also received a grant of 7,900 restricted stock units, which convert one-for-one into common stock and vest in three equal annual installments beginning March 25, 2027, subject to continued employment. After these transactions, he directly held 83,548 common shares and 91,448 restricted stock units.
CNO Financial Group Chief Actuary Jeremy D. Williams reported equity compensation transactions on common stock and restricted stock units. On February 10, 2026, he acquired 4,916 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023–2025 performance measures. On the same date, 1,443 shares were surrendered back to the company at $43.05 to cover required tax withholding. He also received a grant of 3,200 restricted stock units, which convert into common stock on a one-for-one basis and vest in three equal annual installments beginning March 25, 2027, subject to continued employment.
A holder of CNO common stock filed a notice under Rule 144 to sell 30,970 shares through Morgan Stanley Smith Barney LLC on the NYSE. The aggregate market value of the planned sale is listed as $1,329,582.36.
The shares are shown as having been acquired on 02/12/2026 via a stock option exercise, paid in cash, in the same amount of 30,970 shares. The filing notes that 95,353,512 shares of this class were outstanding, providing a baseline for the size of the proposed sale.
CNO Financial Group filed a Form 13F reporting its institutional holdings. The filing lists 19 holdings with a Form 13F information table value total of $176,492,399. The report is signed by Joel T. Koehneman and dated 02-12-2026.
This filing is a routine quarterly disclosure of long positions by an institutional manager and lists the number and aggregate value of reported holdings.
CNO Financial Group, Inc. declared a quarterly cash dividend of $0.17 per common share. The dividend is payable on March 24, 2026 to shareholders of record at the close of business on March 10, 2026.
The company set its annual meeting of shareholders for May 12, 2026, to be held via a virtual live webcast at 8:00 a.m. ET. Holders of record at the close of business on March 16, 2026 will be able to participate, vote and submit questions during the meeting.
CNO also announced that Director Mary R. (Nina) Henderson will retire from the Board at the end of her current term upon the close of the 2026 annual meeting. Her decision was not based on any disagreement with the company regarding its operations, policies or practices.
CNO Financial Group, Inc. furnished materials summarizing its financial performance for the quarter ended December 31, 2025. The company issued a press release, a quarterly financial supplement, and additional financial and operating information, all dated February 5, 2026.
These materials are attached as Exhibits 99.1, 99.2, and 99.3 and are described as being furnished rather than filed, which means they are not subject to certain Exchange Act liabilities or automatically incorporated into other securities filings unless specifically referenced.
CNO Financial Group’s Chief Accounting Officer, Joel T. Koehneman, reported an automatic share surrender related to equity compensation. On 01/21/2026, 158 shares of CNO common stock were surrendered to the company at $41.07 per share to cover required tax withholding on vested restricted stock units, rather than being sold on the open market. After this tax-related transaction, Koehneman directly beneficially owned 3,192 shares of CNO common stock.
CNO Financial Group director Linda T. Gibson reported an equity award of common stock. On January 15, 2026, she received 1,243 shares of CNO common stock, shown at a price of $42.1 per share. The award is described as immediately vesting restricted stock units granted under the company’s Amended and Restated Long-Term Incentive Plan.
Following this grant, Gibson is reported as beneficially owning 1,243 common shares, held directly in her name.